Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma
Recruiting
- Conditions
- Hepatocellular CarcinomaHepatectomyLaparoscopic Hepatectomy
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06950827
- Locations
- 🇨🇳
West China Hospital, Chengdu, Sichuan, China
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
Recruiting
- Conditions
- Sarcomatoid CarcinomaLiver CancerAdjuvant Therapy
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06950814
- Locations
- 🇨🇳
West China Hospital, Chengdu, Sichuan, China
Multi-component Real-time Remote Rehabilitation in Sarcopenia
Not Applicable
Not yet recruiting
- Conditions
- Sarcopenia
- First Posted Date
- 2025-04-20
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 104
- Registration Number
- NCT06937073
Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor MalignanciesAdvanced Solid Malignancies
- Interventions
- Biological: Engineered mitochondria vaccine
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT06927297
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Hepatic Arterial Infusion Chemotherapy (HAIC) Combined with Durvalumab and Lenvatinib in Patients with Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)
Phase 2
Recruiting
- Conditions
- Intrahepatic Cholangiocarcinoma (Icc)HAICDurvalumab
- Interventions
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT06859684
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06798363
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Sichuan, China
HRS-4642 Combined with Nimotuzumab in the Treatment of Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma
Phase 1
Recruiting
- Conditions
- Pancreatic Ductal Adenocarcinoma (PDAC)
- Interventions
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT06773130
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma
Completed
- Conditions
- GliomaGlioma : Oligodendroglioma or Astrocytoma
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 192
- Registration Number
- NCT06885333
The Application of Artificial Intelligence in Wrist and Hand Joint Ultrasound
Recruiting
- Conditions
- EducationJoint Diseases
- First Posted Date
- 2025-03-19
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT06883669
- Locations
- 🇨🇳
Xinyi Tang, Chengdu, Sichuan, China
Effects of Surgical Timing on Perioperative Clinical Outcomes in Pancreaticoduodenectomy
Completed
- Conditions
- Pancreaticoduodenal; FistulaSurgery TimingPerioperative Complication
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 350
- Registration Number
- NCT06874660
- Locations
- 🇨🇳
Xinrui Zhu, Changzhou, Jiangsu, China
© Copyright 2025. All Rights Reserved by MedPath